units

PAC4462

Faculty of Pharmacy and Pharmaceutical Sciences

18 September 2017 22 December 2024
Monash University

Undergraduate - Unit

This unit entry is for students who completed this unit in 2015 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

LevelUndergraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedMalaysia Second semester 2015 (Day)
Parkville Second semester 2015 (Day)
Coordinator(s)Professor Colin Pouton (Parkville); Mr Benny Efendie (Malaysia)

Synopsis

This unit aims to lay a foundation of knowledge about diseases and disorders in neurology and oncology and to provide the relationship between pathophysiology and the rational design and use of drugs in the management of conditions of this type.

The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.

Drug therapy principles for particular conditions and patient groups will be emphasised enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.

Specifically the unit will cover epilepsy, migraine, multiple sclerosis, Parkinson's disease, stroke and a range of common malignancies such as breast cancer, prostate cancer, bowel cancer, skin cancer, leukaemia, lung cancer, etc.

It will also deal with principles of palliative care and management of patients at the end of life.

Students will perform a number of tasks which will help with the development of critical thinking skills and oral and/or written communication skills.

Outcomes

  1. This unit aims to lay a foundation of knowledge about diseases and disorders in neurology and oncology and to provide the relationship between pathophysiology and the rational design and use of drugs in the management of conditions of this type.
  2. The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.
  3. Drug therapy principles for particular conditions and patient groups will be emphasised enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.
  4. Specifically the unit will cover epilepsy, migraine, multiple sclerosis, Parkinson's disease, stroke and a range of common malignancies such as breast cancer, prostate cancer, bowel cancer, skin cancer, leukaemia, lung cancer, etc. It will also deal with principles of palliative care and management of patients at the end of life.
  5. Students will perform a number of tasks which will help with the development of critical thinking skills and oral and written communication skills.

Assessment

Final exam (3 hour): 60%; in-semester MCQ or short answer tests: 20%; practical assessments (case-based exercises): 20%.

Workload requirements

Contact hours for on-campus students:

  • Thirty six 1-hour lectures or equivalent, delivered face to face or online
  • Directed tasks in the form of online group exercises (equivalent to two 6-hour exercises)

See also Unit timetable information

Chief examiner(s)

Professor Colin Pouton

Prerequisites

PAC4451

Additional information on this unit is available from the faculty at:

http://www.monash.edu/pharm/current/